Overall, these results highlight the presence of complex anti- and pro-tumorigenic interactions in the BLCA TME that may shape the anti-tumour function of the CD56bright NK-mDC-CD8+T cell axis. The gene discussed is CD8A; the disease is bladder transitional cell carcinoma.